Nevertheless, 44 patients with Spetzler-Martin Grade I or II lesions eventually chose radiosurgery for their treatment.
Radiosurgical Treatment
After their heads had been immobilized in the Leksell stereotactic head frame, the patients underwent stereotactic imaging to obtain precise information on the shape, volume, and three-dimensional coordinates of the AVM nidus. We usually induce local anesthesia by intravenous administration of sedative drugs, although in one 4-year-old boy, general anesthesia was induced for frame fixation, radiographic examinations, and radiosurgical treatment. The definition of the nidus and localization of the target were obtained from biplanar stereotactic cerebral angiograms. In 70 patients treated after March 1992, high-resolution thinsliced stereotactic CT scanning was used in combination with angiography. Radiosurgery was performed using a 201-source 60 Co gamma knife (Elekta Instruments, Inc., Norcross, GA). Dose planning was performed jointly by neurosurgeons and radiation oncologists with the aid of commercially available software (KULA or Leksell GammaPlan; Elekta Instruments, Inc.). In principle, the dose applied to the margins of the nidus was designed to be greater than 20 Gy by using 50% isodose lines. A summary of applied dose planning is provided in Table 1 .
Follow-Up Evaluation and Statistical Analysis
Follow-up clinical examinations were performed at our hospital or by referring physicians. Either CT or MR imaging was performed every 6 months. Cerebral angiography was recommended at 3 years after radiosurgery, but in patients in whom the AVM had disappeared on CT or MR images, cerebral angiography was performed earlier. Imaging studies were assessed by neuroradiologists and neurosurgeons jointly. The actuarial rates of nidus obliteration and the risks of hemorrhage were calculated using the KaplanMeier method. Factors potentially affecting nidus obliteration and hemorrhage after radiosurgery were evaluated by performing the log-rank test for univariate analysis. The Mann-Whitney rank test was used to evaluate possible as- 
Results
There were 42 male and 58 female patients in the study population, and their ages ranged from 4 to 19 years (median 15 years). Follow-up periods ranged from 6 to 124 months (median 71 months). Fifty-six patients were younger than 15 years old and 20 were younger than 10 years old. In 79 patients, the initial symptoms were caused by hemorrhage from 1 to 117 months before GKS (median 6 months), and in 59 of these patients the hemorrhage had occurred less than 1 year before radiosurgery. At the time of radiosurgery, 62 patients presented with no neurological deficit. Sixty-eight patients underwent GKS as the initial treatment. Thirty-two patients were referred to our department for treatment of a residual AVM nidus after the initial treatment. Before they underwent GKS, 12 patients had undergone resection, 18 endovascular embolization, and two patients endovascular treatment followed by resection. Among the 20 patients in whom previous embolization had been performed, the embolized portion of the lesion was not included in the treatment volume in six cases and was included in the treatment volume in the remaining 14 cases after evaluation with CT scanning. The clinical characteristics of patients and the associated radiographic findings at the time of radiosurgery are summarized in Table 1 .
Results of Imaging Response
Follow-up cerebral angiography was performed in 82 patients, and obliteration of the nidus was confirmed in 71 between 6 and 58 months after radiosurgery (median 21.5 months). The other 11 patients were followed for 13 to 124 months (median 112 months), and in one patient hemorrhage occurred 25 months after radiosurgery. The size of the nidus was unchanged as of the last follow-up examination in five of these 11 patients, and the size of the nidus was decreasing but not totally occluded in six. In none of the cases was there enlargement of the nidus. The actuarial rates of nidus obliteration evaluated on angiography were 84.1% at 3 years, 89.4% at 4 years, and 94.7% at 5 years ( Fig. 1) . The remaining 18 patients were observed using MR imaging and the disappearance of the abnormal flow-void signal was observed in four patients. Of the remaining 14 patients, the nidus size was unchanged as of the last follow-up examination in eight cases, and the size was decreasing but not totally occluded in six. In none of the cases was there enlargement of the nidus. When the four cases in which there was a loss of flow void on MR images were counted as having complete obliteration of the lesion, the actuarial rates of nidus obliteration in 100 patients were 83.1% at 3 years, 79.9% at 4 years, and 94% at 5 years. On the other hand, when those four cases were counted as having a residual nidus, the actuarial rates were 81.1% at 3 years, 86.5% at 4 years, and 93.3% at 5 years.
Factors investigated for possible association with angiographically verified nidus obliteration are listed in Table 2 . Of those, factors significantly associated with a better obliteration rate in the univariate analysis were age of 12 years or younger, mean nidus diameter of 2 cm or smaller, nidus volume of 3.8 cm 3 or less, maximum diameter of the nidus less than 3 cm, and a Spetzler-Martin grade of III or lower.
Radiation-Induced Complications
In 15 patients, preexisting neurological symptoms caused by previous hemorrhage improved gradually during the fol-
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Radiosurgery for AVMs in children and adolescents low-up periods (hemiparesis in 10, aphasia in six, dysesthesia in three patients, and cerebellar signs and abducent nerve palsy in one patient each). None of the patients presented with symptoms or signs suggestive of an endocrinological abnormality such as hypopituitarism.
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Follow-up MR images demonstrated radiation-induced edema in 26 patients 5 to 19 months after radiosurgery (median 10.5 months), and neurological deterioration was observed in four of them 1 to 19 months (median 7.5 months) after radiosurgery. Symptoms were transient in two patients: oculomotor palsy in a patient with a midbrain AVM, which lasted 5 months and deterioration of preexisting paresis in a patient with an AVM in the motor cortex, which lasted 21 months. The neurological symptoms did not resolve in two patients who experienced with visual field disturbance 8 and 19 months, respectively, after radiosurgery; one patient harbored an AVM in the occipital lobe and the other harbored a lesion in the posterior temporal lobe. Factors found to be associated with neurological deterioration after radiosurgery during univariate testing were nidus location in the brainstem (p = 0.0285) and a maximum radiation dose higher than 40 Gy (p = 0.0447).
Risks of Hemorrhagic Events
In four patients hemorrhage developed from AVMs before obliteration of the nidus was confirmed on angiography 22 to 59 months after radiosurgery (median 40.5 months), and in two of those patients a chronic encapsulated expanding hematoma developed. 17 Two patients recovered without neurological sequelae, but one patient with a chronic expanding hematoma was severely disabled, despite surgical removal of the hematoma and another patient with a cerebellar AVM died of the hemorrhage. The annual bleeding rate was 1.5%. Feeding arteries in the posterior cranial fossa (p = 0.0071) and nidus location in the cerebellum (p = 0.001) were significantly associated with hemorrhage occurring within the latency interval in univariate testing.
Twenty of 71 patients with angiographically confirmed nidus obliteration did not agree to further follow-up review, but the remaining 51 patients were further followed for 1 to 110 months (median 67 months). Magnetic resonance images were obtained only if residual brain edema was identified on the last MR image (10 cases) or if the patient demonstrated new clinical symptoms (one case). Of the 51 cases in which the postobliteration follow-up review was conducted, 50 patients displayed no sign of neurological deterioration, but hemorrhage developed at the site of the lesion in one patient. This patient was an 18-year-old woman who initially presented with scintillating scotoma and was found to harbor an AVM in the right occipital lobe. A cerebral angiogram obtained 47 months after radiosurgery revealed complete obliteration of the AVM and no early venous filling suggestive of remaining shunting. Nevertheless, 38 months after angiographically confirmed obliteration of the nidus (75 months after radiosurgery), she experienced acute intracerebral hemorrhage at the site where the nidus had been located (Fig. 2 upper left) . A residual nidus was not detected by repeated angiography (Fig. 2 upper  right and lower left) , although MR imaging revealed abnormal enhancement of the site of the nidus (Fig. 2 lower  right) . Following the hemorrhage a quadrant hemianopsia developed, but the patient experienced no further neurological deterioration. She has been carefully observed without any additional treatment and her condition remains stable 2 years after the hemorrhage.
Discussion
In the treatment of childhood AVMs, it is important to realize that disappearance of the AVM nidus on angiograms may not be the endpoint of follow-up review. Even after total surgical removal of the nidus was confirmed with postoperative angiography, recurrence and rebleeding has occasionally been reported. 6, 15, 33 This phenomenon has been considered to be related to the inherent nature of original abnormal vasculature. Immature vasculature is more likely to be part of the AVM in children, although it may not be visible on postoperative angiography. 6 If these immature vessels are left in the surgical bed, they may retain the ability to regrow and potentially form new malformations in the same or adjacent cerebral regions. This is apparently true for radiosurgically treated AVM: although very rare, recanalization or late hemorrhage of the treated AVM nidus more than 5 years after angiographically confirmed nidus obliteration has been reported. 19, 32 We also treated one patient in whom hemorrhage developed 38 months after angiography confirmed obliteration of the nidus. The cerebral angiogram revealed no sign of recurrence or recanalization of the treated AVM, but the site of the nidus was still enhanced on MR images. Because the long-term outcome of radiosurgery (Ͼ 10 years posttreatment) is not well known at present, young patients with AVMs should be informed of the need for follow-up review, even after angiographic obliteration has been confirmed, before receiving radiosurgery.
Despite the lack of longer follow-up data, radiosurgery still seems to be useful in preventing disastrous hemorrhage from the AVM nidus. In our series, GKS for AVMs in patients younger than 20 years achieved more than a 93% actuarial nidus obliteration at 5 years, with a 1.5% annual risk of hemorrhage during the latency interval. Patients younger than 12 years of age displayed an even better treatment response. These results are concordant with those of several previous reports positing 94 to 100% obliteration rates with 0 to 2.5% annual risks of hemorrhage during the latency interval, 18, 27, 31 and indicate that stereotactic radiosurgery seems to be an acceptable treatment option for AVMs in such a young population.
14, 25 The better results of treatment in these young patients, compared with results in the general population, which have been reported to be 70 to 87% rates of nidus obliteration with 1.8 to 5% annual risks of hemorrhage, 2, 13, 16, 18, 20, 26, 28 may suggest a stronger reaction of vascular endothelium to radiation in younger patients.
The results of our study also show that there are factors affecting outcomes of radiosurgery that should be taken into consideration before offering radiosurgery as an alternative treatment option. First, the size of the nidus at radiosurgery significantly affected the obliteration rate. In 42 AVMs with a mean nidus diameter of 1.5 cm or less (range 0.6-1.5 cm, median 1.2 cm), the actuarial rate of nidus obliteration was 96% at 3 years, whereas it dropped to 58.6% in 19 AVMs with mean diameters larger than 2 cm (range 2-3.3 cm, median 2.1 cm). Therefore, small AVMs seem to be good candidates for radiosurgery. We have to note, however, that such small lesions, especially when located in noneloquent areas, are also good candidates for microsurgery, with reports of large series citing mortality rates of approximately 0% and morbidity rates not exceeding 5%. Second, the location of feeding arteries in the posterior cranial fossa or location of the nidus in the cerebellum was significantly associated with a higher risk of hemorrhage during the latency interval. Because significant rates of mortality have been reported in young patients experiencing hemorrhage from an AVM in the cerebellum or brainstem, 10, 15 patients with an AVM in the posterior cranial fossa would face a higher risk of fatal hemorrhage during the latency period following radiosurgery. Given such a relatively high risk of treatment failure, the feasibility of surgery should be seriously considered for those patients with a larger nidus or a nidus located in the cerebellum. For small AVMs in the brainstem, especially those with an intraparenchymal nidus, radiosurgery would be recommended because safe resection is difficult and severe neurological deterioration is anticipated. 16, 29 Even in such cases, it would be necessary to notify patients and their parents of a relatively higher risk of transient neurological deterioration and fatal hemorrhage occurring during the latency interval.
Radiosurgery is a relatively new treatment modality and our knowledge of its long-term risks is still limited. One potential risk is the possibility of radiation-induced neoplasms, and there have been a few reports describing suspicious cases. 12 Even though such a risk must be very small, the cumulative risk should be much higher in children and adolescents with long lives ahead of them. Therefore, such a possible risk should be recognized before selecting the treatment.
Conclusions
We consider stereotactic radiosurgery to be acceptable as an alternative treatment for small AVMs in children and adolescents in whom a higher obliteration rate was achieved with lower risks of hemorrhage occurring during the latency period and infrequent negative neurological events. Nevertheless, we also have to note that many such lesions are also good candidates for resection and, before making a decision, treatment options should be discussed with patients and their families in detail with all available information. When radiosurgery is selected, we should continue to observe patients carefully, even after angiographic obliteration has been confirmed following radiosurgery.
